MENU
+Compare
IBBQ
ETF ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$21.61
Change
-$0.89 (-3.96%)
Net Assets
39.66M

IBBQ stock forecast, quote, news & analysis

Category: @Health
IBBQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
A.I.Advisor
a Summary for IBBQ with price predictions
Dec 17, 2024

IBBQ in downward trend: price dove below 50-day moving average on November 12, 2024

IBBQ moved below its 50-day moving average on November 12, 2024 date and that indicates a change from an upward trend to a downward trend. In of 25 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on IBBQ as a result. In of 60 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IBBQ turned negative on December 12, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for IBBQ crossed bearishly below the 50-day moving average on November 15, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBBQ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IBBQ's RSI Indicator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IBBQ advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

IBBQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 143 cases where IBBQ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Nasdaq Biotechnology ETF ETF is 6.91B. The market cap for tickers in the group ranges from 13.63M to 208.98B. AZN holds the highest valuation in this group at 208.98B. The lowest valued company is MRNS at 13.63M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was 22%. For the same ETF, the average monthly price growth was 154%, and the average quarterly price growth was 389%. ALXO experienced the highest price growth at 13%, while KROS experienced the biggest fall at -73%.

Volume

The average weekly volume growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was -8%. For the same stocks of the ETF, the average monthly volume growth was -35% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 78
Price Growth Rating: 58
SMR Rating: 88
Profit Risk Rating: 82
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
IBBQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
PowerShares Exchange-Traded Fund Tr II301 West Roosevelt RoadWheaton
Phone
N/A
Web
www.invescopowershares.com